The CDC states that vaginal washing or douching after sexual exposure does not prevent HIV or sexually transmitted infections and may increase the risk of bacterial vaginosis and other infections. ACOG similarly advises women not to douche because it can disturb the normal vaginal microbiome.¹⁻³
Now comes Livi, an FDA-cleared device inserted after intercourse to absorb semen and vaginal discharge.
Livi is not a douche. It does not irrigate the vagina or introduce a cleansing solution. That distinction matters.
But its marketing relies on a remarkably familiar message: something has been left inside the vagina after sex, it disrupts the vaginal environment, and women should remove it.
The website explains that semen is alkaline, the vagina is acidic, and semen can temporarily alter vaginal pH and the microbiome. These statements describe physiology. They do not establish disease.
Semen does temporarily raise vaginal pH. Recent research also suggests that condomless intercourse can produce short-term changes in vaginal bacterial composition.⁴
But demonstrating a biologic change is not the same as demonstrating harm. Eating changes blood glucose. Exercise changes cortisol. Menstruation changes vaginal pH. Not every measurable change requires correction.
The critical clinical question is not whether Livi absorbs semen. It does. The question is whether removing semen improves health.
There is no evidence that it does.
The company says so itself:
“There is no evidence to support that Livi prevents BV.”
That disclosure should frame every claim made about “vaginal wellness,” “pH balance,” and the microbiome.
The published Livi study was manufacturer-funded and nonrandomized. Of 542 enrolled women, 291 completed the post-use questionnaire. Most reported less dripping, discharge, and odor. In a subset of only 48 women, self-measured vaginal pH returned toward baseline somewhat faster with the device.⁵
Those findings may support a convenience benefit. They do not establish a health benefit.
The study did not measure bacterial vaginosis, candidiasis, urinary tract infection, sexually transmitted infection, or any other clinical outcome. It did not analyze the vaginal microbiome. It was not blinded or sham-controlled, and the participants were specifically interested in a product of this kind. The investigators appropriately acknowledged that the clinical significance of the pH change remains unknown.
“FDA cleared” does not fill this evidentiary gap. Livi received 510(k) clearance as substantially equivalent to an unscented tampon for absorbing fluid.⁶ The clearance supports its absorptive function and short-term safety. It does not mean that the FDA determined semen to be harmful, that postcoital pH changes require treatment, or that using Livi prevents disease.
There is nothing inherently unethical about selling convenience. Some women dislike postcoital leakage or odor and may reasonably prefer a device that absorbs fluid. Their discomfort should not be dismissed.
The ethical problem begins when convenience is surrounded by biomedical language that implies prevention or protection without evidence of either. “Supports vaginal wellness” sounds clinical. “Before fluids have time to mess with your pH” sounds preventive.
Discussion of microbiome disruption invites women to infer that leaving semen in the vagina is unhealthy, even while the company carefully avoids claiming that removing it improves health.
Women have spent generations being incorrectly told that their normal bodies are unclean, odorous, or in need of correction. Modern marketing should not revive that message by replacing the language of hygiene with the language of pH and microbiomes.
The Livi website says a great deal about what semen does to the vagina. It does not show that these temporary changes are harmful. Even a superficial reading shows that Livi makes no demonstrated claim that its use produces a health benefit.
That should sit uncomfortably with everyone.
References
Centers for Disease Control and Prevention. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187.
American College of Obstetricians and Gynecologists. Vulvovaginal Health.
Brotman RM, Klebanoff MA, Nansel TR, et al. A longitudinal study of vaginal douching and bacterial vaginosis: a marginal structural modeling analysis. Am J Epidemiol. 2008;168(2):188-196.
Park DE, et al. Post-coital dynamics of the penile and cervico-vaginal genital microbiomes. Microbiome. 2026.
Ingber M, et al. Patient Satisfaction With a Novel Postcoital Intravaginal Fluid-Absorbing Device. O&G Open. 2026.
US Food and Drug Administration. Livi Device 510(k) Summary, K252005. 2026.